| BGF EMERGING MARKETS EQUITY INCOME D5G GBP | RVI EMERGENTES | 24,40% | 60,30% | 30,91% | · |
| FRANKLIN GENOMIC ADVANCEMENTS A (ACC) EUR-H1 | RVI BIOTECNOLOGÍA | 24,40% | 49,28% | · | · |
| INVESCO NIPPON SMALL/MID CAP EQUITY A DIS ANNUAL USD | RVI JAPÓN SMALL/MID CAP | 24,40% | 65,85% | 14,35% | 58,13% |
| JPM JAPAN SUSTAINABLE EQUITY D (ACC) JPY | RVI JAPÓN | 24,40% | 63,82% | 34,89% | 87,86% |
| VONTOBEL FUND-MTX EMERGING MARKETS LEADERS G USD CAP | RVI EMERGENTES | 24,40% | 76,03% | 38,76% | · |
| AXA WORLD FUNDS-GLOBAL SMALL CAP EQUITY QI E CAP EUR | RVI GLOBAL SMALL/MID CAP | 24,39% | 42,58% | -11,04% | 42,51% |
| DWS ESG AKKUMULA ID | RVI GLOBAL | 24,39% | 68,11% | 72,87% | 209,52% |
| DWS INVEST CROCI SECTORS PLUS LC | RVI GLOBAL | 24,39% | 30,53% | 53,57% | 184,03% |
| HSBC GIF GLOBAL EMERGING MARKETS EQUITY AC EUR | RVI EMERGENTES | 24,39% | 76,78% | 33,83% | 102,26% |
| RBC FUNDS (LUX)-EMERGING MARKETS EQUITY FOCUS FUND A CAP USD | RVI EMERGENTES | 24,39% | 76,66% | 62,49% | · |
